Stericycle (SRCL) PT Lowered to $62.00 at BMO Capital Markets

Stericycle (NASDAQ:SRCL) had its price objective cut by research analysts at BMO Capital Markets from $74.00 to $62.00 in a research note issued on Friday, November 10th. The brokerage currently has a “market perform” rating on the business services provider’s stock. BMO Capital Markets’ price target would suggest a potential downside of 5.04% from the company’s current price.

A number of other research analysts also recently issued reports on the company. Stifel Nicolaus reiterated a “buy” rating and set a $85.00 price objective (down from $95.00) on shares of Stericycle in a research note on Thursday, November 9th. Royal Bank Of Canada lowered their price target on Stericycle from $74.00 to $67.00 and set an “underperform” rating on the stock in a report on Thursday, November 9th. Jefferies Group set a $108.00 price target on Stericycle and gave the stock a “buy” rating in a report on Tuesday, October 17th. Zacks Investment Research cut Stericycle from a “hold” rating to a “sell” rating in a report on Wednesday, October 4th. Finally, William Blair reaffirmed an “ourperform” rating on shares of Stericycle in a report on Thursday, September 14th. Four equities research analysts have rated the stock with a sell rating, three have given a hold rating and six have issued a buy rating to the stock. Stericycle presently has a consensus rating of “Hold” and an average target price of $76.73.

Stericycle (SRCL) opened at $65.29 on Friday. The company has a debt-to-equity ratio of 0.93, a current ratio of 0.82 and a quick ratio of 0.82. The stock has a market capitalization of $5,450.00, a PE ratio of 14.53, a PEG ratio of 1.54 and a beta of 0.19. Stericycle has a 52-week low of $61.25 and a 52-week high of $88.00.

Stericycle (NASDAQ:SRCL) last released its quarterly earnings results on Wednesday, November 8th. The business services provider reported $1.10 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.14 by ($0.04). The firm had revenue of $883.00 million for the quarter, compared to the consensus estimate of $896.81 million. Stericycle had a negative net margin of 0.79% and a positive return on equity of 13.93%. The company’s revenue for the quarter was down .8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.24 earnings per share. research analysts expect that Stericycle will post 4.49 earnings per share for the current year.

In other Stericycle news, Director Mark C. Miller sold 19,753 shares of the company’s stock in a transaction on Monday, November 13th. The stock was sold at an average price of $64.03, for a total value of $1,264,784.59. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Insiders have sold a total of 59,259 shares of company stock worth $3,908,724 in the last 90 days. 3.50% of the stock is currently owned by insiders.

Several institutional investors and hedge funds have recently bought and sold shares of the company. Pacer Advisors Inc. boosted its position in Stericycle by 8.4% during the second quarter. Pacer Advisors Inc. now owns 1,880 shares of the business services provider’s stock valued at $143,000 after purchasing an additional 145 shares in the last quarter. NEXT Financial Group Inc boosted its position in Stericycle by 77.9% during the third quarter. NEXT Financial Group Inc now owns 2,322 shares of the business services provider’s stock valued at $164,000 after purchasing an additional 1,017 shares in the last quarter. Benjamin F. Edwards & Company Inc. boosted its position in Stericycle by 8.5% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 2,540 shares of the business services provider’s stock valued at $194,000 after purchasing an additional 200 shares in the last quarter. ARGI Investment Services LLC bought a new stake in Stericycle during the third quarter valued at about $215,000. Finally, Zions Bancorporation bought a new stake in Stericycle during the third quarter valued at about $233,000. 94.59% of the stock is currently owned by institutional investors and hedge funds.

TRADEMARK VIOLATION NOTICE: “Stericycle (SRCL) PT Lowered to $62.00 at BMO Capital Markets” was reported by BBNS and is the sole property of of BBNS. If you are viewing this news story on another website, it was stolen and reposted in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://baseballnewssource.com/markets/stericycle-inc-srcl-price-target-cut-to-62-00/1775967.html.

About Stericycle

Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.

Analyst Recommendations for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Yankees and Marlins Continue Stanton Trade Talks
Yankees and Marlins Continue Stanton Trade Talks
Marlins Making Moves, Trade Dee Gordon to Seattle
Marlins Making Moves, Trade Dee Gordon to Seattle
Report: Astros Dallas Keuchel Pitched With Injured Foot
Report: Astros Dallas Keuchel Pitched With Injured Foot
Angels Sign Former Prospect with Braves Kevin Maitan
Angels Sign Former Prospect with Braves Kevin Maitan
Shohei Ohtani Has Turned Down Red Sox and Yankees
Shohei Ohtani Has Turned Down Red Sox and Yankees


Leave a Reply

 
© 2006-2017 BBNS.